Prostate Cancer Statistics
IMAGIN’S CLINICAL SOLUTION
enCAGE Coil™ Precision Ablation System for Prostate Cancer
Focal Therapy with the enCAGE Coil
The enCAGE Coil is being refined to address the limitations of other methods of prostate cancer treatment that can cause impaired urinary and sexual function. The device is a disposable, focal therapy precision ablation system that will delivers bipolar, radiofrequency energy through a distinctive coil electrode, or “cage” and allow the surgeon to preset margins for precise tissue targeting. Similar to the principle of the Faraday Effect, the enCAGE coils retains the RF energy within the confines of the coil, preventing leakage beyond the ablation zone that could otherwise damage adjacent erectile nerves. The procedure is minimally invasive can be performed in a physician’s office.
Two clinical studies were completed on 41 patients by Dr. Samir Taneja, NYU/Langone Medical Center, Dr. Mark Emberton, University College London and Dr. Clement Orczyk, that showed negative biopsy results in 71 and 80% of subjects within six months following treatment, respectively. Results of the University College London study were published in Journal of Urology, May 2018.
The enCAGE received an initial FDA 510(k) clearance in 2008 for percutaneous, laparoscopic, or intraoperative thermal coagulation of soft tissues. Product enhancements are under development. The product has strong intellectual property with 8 issued patents.